Odisha sees surge in fake medicines; 4 suppliers blacklisted in 3 years

Bhubaneswar: Odisha registered a huge surge in counterfeit or fake medicines in a past few years, putting lives of many patients at risk.

This was revealed from a statement by Odisha Health & Family Welfare Minister Dr. Mukesh Mahaling in Assembly today.

According to reports, the fake medicines were supplied from other places like Uttar Pradesh, Madhya Pradesh, Kolkata and Hyderabad.

Replying to a query by BJP’s Dharamgarh MLA Sudhir Ranjan Pattjoshi, the Minister stated that 103 medicines procured by Odisha State Medical Corporation were found substandard and 4 suppliers have been blacklisted in past 3 years.

“Total 45 tablets and Ringer’s Lactate including Zinc Suplphate, Sodium Lactate were declared as substandard in 2022-23 FY, 32 medicines were found falsified during 2023-24 FY and 26 fake medicines were found fake in 2024-25 FY,” Dr. Mahaling stated.

As part of measure to prevent supply of counterfeit medicines in the state, the government has blacklisted four suppliers so far. The blacklisted pharmaceutical firms were LA CHEMICO Pvt Ltd, Kolkata; Swaroop Pharmaceutical Pvt Ltd, Uttar Pradesh; Ives Drugs India Pvt Ltd, Madhya Pradesh; and Alliance Biotech, Hyderabad, he said.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit